Amersham logoAnswering life's questions - Annual Report & Accounts 2001
Points of viewThe ReportMarket reports
DownloadsHome
Our vision, from different points of view
Print this page Next page
  Previous page  

The Hospital AdministratorThe InvestorThe Doctor
The PatientThe EmployeeThe Scientist
The NeighbourThe Parent
"Why do I find myself saying 'If only this patient had come to me earlier?'" - The Doctor
 


Timing. This is the key to more effective treatment. The earlier our products are used to help diagnose a disease, the earlier you can deal with it. Time is of the essence when a patient suffers an apparent heart attack. Our heart imaging product, Myoview, can quickly and accurately demonstrate which areas of the heart are affected and how serious the damage is. Myoview has proved so effective in visualising blood flow to the heart muscle that it's used every 18 seconds to examine a heart patient in the US.

We're also working to expand the role of imaging beyond diagnosis. Predictive screening will detect disease earlier. Already, our DaTSCAN product can detect the first signs of Parkinson's Disease and differentiate this condition from other, less serious brain disorders. This will become invaluable as new therapies evolve for treating Parkinson's Disease earlier. Ultimately, we aim to diagnose disease before it becomes apparent. We can't stop the clock, but we're doing our bit to stop disease.



Overview of Amersham Health
Overview of Amersham Biosciences
Visionaries: a new era of personalised medicine
Latest news
   
Previous pageNext page

© Amersham plc - All rights reserved  Privacy policy - Terms & conditions - GE Healthcare